7630 — IMPACT Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.94bn
- HK$2.99bn
- CNY38.25m
Annual cashflow statement for IMPACT Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -255 | -296 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 56.3 | 130 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 111 | 65.6 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -81.3 | -95.9 |
| Capital Expenditures | -1.7 | -1.51 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | -108 | 114 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | -110 | 113 |
| Financing Cash Flow Items | -299 | -4.49 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 148 | 13.5 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -41.2 | 28.4 |